Vinflunine Shown to Improve Response and Survival in Mesothelioma

A novel microtubule inhibitor, high-dose vinflunine, is yielding encouraging response and survival rates in patients with malignant pleural mesothelioma.

This entry was posted on Thursday, May 15th, 2008 at 10:27 am and is filed under Mesothelioma News. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.